These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 28277309)

  • 1. Differential gene expression profiles in neurons generated from lymphoblastoid B-cell line-derived iPS cells from monozygotic twin cases with treatment-resistant schizophrenia and discordant responses to clozapine.
    Nakazawa T; Kikuchi M; Ishikawa M; Yamamori H; Nagayasu K; Matsumoto T; Fujimoto M; Yasuda Y; Fujiwara M; Okada S; Matsumura K; Kasai A; Hayata-Takano A; Shintani N; Numata S; Takuma K; Akamatsu W; Okano H; Nakaya A; Hashimoto H; Hashimoto R
    Schizophr Res; 2017 Mar; 181():75-82. PubMed ID: 28277309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylation Analysis in Monozygotic Twins With Treatment-Resistant Schizophrenia and Discordant Responses to Clozapine.
    Kikuchi M; Nakazawa T; Kinoshita M; Yamamori H; Yasuda Y; Fujimoto M; Hashimoto R; Numata S
    Front Psychiatry; 2021; 12():734606. PubMed ID: 34616320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developmental dysregulation of excitatory-to-inhibitory GABA-polarity switch may underlie schizophrenia pathology: A monozygotic-twin discordant case analysis in human iPS cell-derived neurons.
    Toritsuka M; Yoshino H; Makinodan M; Ikawa D; Kimoto S; Yamamuro K; Okamura K; Akamatsu W; Okada Y; Matsumoto T; Hashimoto K; Ogawa Y; Saito Y; Watanabe K; Aoki C; Takada R; Fukami SI; Hamano-Iwasa K; Okano H; Kishimoto T
    Neurochem Int; 2021 Nov; 150():105179. PubMed ID: 34500023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex-specific transcriptional and proteomic signatures in schizophrenia.
    Tiihonen J; Koskuvi M; Storvik M; Hyötyläinen I; Gao Y; Puttonen KA; Giniatullina R; Poguzhelskaya E; Ojansuu I; Vaurio O; Cannon TD; Lönnqvist J; Therman S; Suvisaari J; Kaprio J; Cheng L; Hill AF; Lähteenvuo M; Tohka J; Giniatullin R; Lehtonen Š; Koistinaho J
    Nat Commun; 2019 Sep; 10(1):3933. PubMed ID: 31477693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating miRNome profiling in Moyamoya disease-discordant monozygotic twins and endothelial microRNA expression analysis using iPS cell line.
    Uchino H; Ito M; Kazumata K; Hama Y; Hamauchi S; Terasaka S; Sasaki H; Houkin K
    BMC Med Genomics; 2018 Aug; 11(1):72. PubMed ID: 30157848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monozygotic twins concordant for response to clozapine.
    Vojvoda D; Grimmell K; Sernyak M; Mazure CM
    Lancet; 1996 Jan; 347(8993):61. PubMed ID: 8531572
    [No Abstract]   [Full Text] [Related]  

  • 7. Clozapine: weight gain in a pair of monozygotic twins concordant for schizophrenia and mild mental retardation.
    Wehmeier PM; Gebhardt S; Schmidtke J; Remschmidt H; Hebebrand J; Theisen FM
    Psychiatry Res; 2005 Feb; 133(2-3):273-6. PubMed ID: 15741002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment of an induced pluripotent stem cell (iPSC) line from a patient with Clozapine-responder Schizophrenia.
    Marcatili M; Marsoner F; D'Agostino A; Karnavas T; Bottai D; Scarone S; Conti L
    Stem Cell Res; 2016 Nov; 17(3):630-633. PubMed ID: 27934596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valproate reverts zinc and potassium imbalance in schizophrenia-derived reprogrammed cells.
    Paulsen Bda S; Cardoso SC; Stelling MP; Cadilhe DV; Rehen SK
    Schizophr Res; 2014 Apr; 154(1-3):30-5. PubMed ID: 24593932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polygenic overlap between schizophrenia risk and antipsychotic response: a genomic medicine approach.
    Ruderfer DM; Charney AW; Readhead B; Kidd BA; Kähler AK; Kenny PJ; Keiser MJ; Moran JL; Hultman CM; Scott SA; Sullivan PF; Purcell SM; Dudley JT; Sklar P
    Lancet Psychiatry; 2016 Apr; 3(4):350-7. PubMed ID: 26915512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Addressing nonresponse in schizophrenia.
    Kane JM
    J Clin Psychiatry; 2012 Feb; 73(2):e07. PubMed ID: 22401484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment-resistant schizophrenia].
    Yahyaten OB
    Rev Med Brux; 2014; 35(3):169-73. PubMed ID: 25102584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Dopamine D4-receptor variants, schizophrenia and clozapine therapy].
    Ewald HL; Mors NP; Rosenberg R
    Ugeskr Laeger; 1996 Jun; 158(25):3601-3. PubMed ID: 8693618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect size of symptom status in withdrawal of typical antipsychotics and subsequent clozapine treatment in patients with treatment-resistant schizophrenia.
    Pickar D; Bartko JJ
    Am J Psychiatry; 2003 Jun; 160(6):1133-8. PubMed ID: 12777272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment pathway and patterns of clozapine prescribing for schizophrenia in New Zealand.
    Wheeler AJ
    Ann Pharmacother; 2008 Jun; 42(6):852-60. PubMed ID: 18477732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extensive gray matter volume reduction in treatment-resistant schizophrenia.
    Anderson VM; Goldstein ME; Kydd RR; Russell BR
    Int J Neuropsychopharmacol; 2015 Feb; 18(7):pyv016. PubMed ID: 25716781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An open comparison of clozapine and risperidone in treatment-resistant schizophrenia.
    Flynn SW; MacEwan GW; Altman S; Kopala LC; Fredrikson DH; Smith GN; Honer WG
    Pharmacopsychiatry; 1998 Jan; 31(1):25-9. PubMed ID: 9524981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Olanzapine versus clozapine in treatment-resistant or treatment-intolerant schizophrenia.
    Bitter I; Dossenbach MR; Brook S; Feldman PD; Metcalfe S; Gagiano CA; Füredi J; Bartko G; Janka Z; Banki CM; Kovacs G; Breier A;
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):173-80. PubMed ID: 14687871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Clozapine on DNA Methylation in Peripheral Leukocytes from Patients with Treatment-Resistant Schizophrenia.
    Kinoshita M; Numata S; Tajima A; Yamamori H; Yasuda Y; Fujimoto M; Watanabe S; Umehara H; Shimodera S; Nakazawa T; Kikuchi M; Nakaya A; Hashimoto H; Imoto I; Hashimoto R; Ohmori T
    Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28335437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: a review and meta-analysis of randomized trials.
    Chakos M; Lieberman J; Hoffman E; Bradford D; Sheitman B
    Am J Psychiatry; 2001 Apr; 158(4):518-26. PubMed ID: 11282684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.